
Illumina
North America, California, United States, San Diego
Description
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Investor Profile
Illumina has made 20 investments, with 2 in the past 12 months and 20% as lead.
Stage Focus
- Series A (20%)
- Series Unknown (15%)
- Series C (15%)
- Seed (15%)
- Pre Seed (10%)
- Series B (5%)
- Post Ipo Equity (5%)
- Corporate Round (5%)
- Series F (5%)
- Series D (5%)
Country Focus
- United States (65%)
- United Kingdom (25%)
- Canada (10%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Genetics
- Biopharma
- Medical
- Bioinformatics
- Personal Health
- Life Science
- Nanotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.